Cargando…
Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth
Alpha-amylase is widely exploited as a drug target for preventing postprandial hyperglycemia in diabetes and other metabolic diseases. Inhibition of this enzyme by plant-derived pregnanes is not fully understood. Herein, we used in vitro, in silico, and in vivo studies to provide further insights in...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399641/ https://www.ncbi.nlm.nih.gov/pubmed/36032689 http://dx.doi.org/10.3389/fmolb.2022.866719 |
_version_ | 1784772570900332544 |
---|---|
author | Ogunyemi, Oludare M. Gyebi, Gideon A. Saheed, Afolabi Paul, Jesse Nwaneri-Chidozie, Victoria Olorundare, Olufunke Adebayo, Joseph Koketsu, Mamoru Aljarba, Nada Alkahtani, Saad Batiha, Gaber El-Saber Olaiya, Charles O. |
author_facet | Ogunyemi, Oludare M. Gyebi, Gideon A. Saheed, Afolabi Paul, Jesse Nwaneri-Chidozie, Victoria Olorundare, Olufunke Adebayo, Joseph Koketsu, Mamoru Aljarba, Nada Alkahtani, Saad Batiha, Gaber El-Saber Olaiya, Charles O. |
author_sort | Ogunyemi, Oludare M. |
collection | PubMed |
description | Alpha-amylase is widely exploited as a drug target for preventing postprandial hyperglycemia in diabetes and other metabolic diseases. Inhibition of this enzyme by plant-derived pregnanes is not fully understood. Herein, we used in vitro, in silico, and in vivo studies to provide further insights into the alpha-amylase inhibitory potential of selected pregnane-rich chromatographic fractions and four steroidal pregnane phytochemicals (SPPs), viz: marsectohexol (P1), 3-O-[6-deoxy-3-O-methyl-β-D-allopyranosyl-(1→14)-β-D-oleandropyranosyl]-11,12-di-O-tigloyl-17β-marsdenin (P2), 3-O-[6-deoxy-3-O-methyl-β-D-allopyranosyl-(1→4)-β-D-oleandropyranosyl]-17β-marsdenin (P3), and 3-O-[6-deoxy-3-O-methyl-β-D-allopyranosyl-(1→4)-β-D-canaropyranosyl]-17β-marsdenin (P4) derived from Gongronema latifolium Benth. The results revealed that the SPPs source pregnane-rich chromatographic fractions and the SPPs (P1–P4) exhibited inhibitory potential against porcine pancreatic alpha-amylase in vitro. Compounds P1 and P2 with IC(50) values 10.01 and 12.10 µM, respectively, showed greater inhibitory potential than the reference acarbose (IC(50) = 13.47 µM). Molecular docking analysis suggests that the SPPs had a strong binding affinity to porcine pancreatic alpha-amylase (PPA), human pancreatic alpha-amylase (HPA), and human salivary alpha-amylase (HSA), interacting with the key active site residues through an array of hydrophobic interactions and hydrogen bonds. The strong interactions of the SPPs with Glu233 and Asp300 residues may disrupt their roles in the acid-base catalytic mechanism and proper orientation of the polymeric substrates, respectively. The interactions with human pancreatic amylase were maintained in a dynamic environment as indicated by the root mean square deviation, radius of gyration, surface accessible surface area, and number of hydrogen bonds computed from the trajectories obtained from a 100-ns molecular dynamics simulation. Key loop regions of HPA that contribute to substrate binding exhibited flexibility and interaction potential toward the compounds as indicated by the root mean square fluctuation. Furthermore, P1 significantly reduced blood glucose levels and area under the curve in albino rats which were orally challenged with starch. Therefore, Gongronema latifolium and its constituent SPPs may be exploited as inhibitors of pancreatic alpha-amylase as an oral policy for impeding postprandial blood glucose rise. |
format | Online Article Text |
id | pubmed-9399641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93996412022-08-25 Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth Ogunyemi, Oludare M. Gyebi, Gideon A. Saheed, Afolabi Paul, Jesse Nwaneri-Chidozie, Victoria Olorundare, Olufunke Adebayo, Joseph Koketsu, Mamoru Aljarba, Nada Alkahtani, Saad Batiha, Gaber El-Saber Olaiya, Charles O. Front Mol Biosci Molecular Biosciences Alpha-amylase is widely exploited as a drug target for preventing postprandial hyperglycemia in diabetes and other metabolic diseases. Inhibition of this enzyme by plant-derived pregnanes is not fully understood. Herein, we used in vitro, in silico, and in vivo studies to provide further insights into the alpha-amylase inhibitory potential of selected pregnane-rich chromatographic fractions and four steroidal pregnane phytochemicals (SPPs), viz: marsectohexol (P1), 3-O-[6-deoxy-3-O-methyl-β-D-allopyranosyl-(1→14)-β-D-oleandropyranosyl]-11,12-di-O-tigloyl-17β-marsdenin (P2), 3-O-[6-deoxy-3-O-methyl-β-D-allopyranosyl-(1→4)-β-D-oleandropyranosyl]-17β-marsdenin (P3), and 3-O-[6-deoxy-3-O-methyl-β-D-allopyranosyl-(1→4)-β-D-canaropyranosyl]-17β-marsdenin (P4) derived from Gongronema latifolium Benth. The results revealed that the SPPs source pregnane-rich chromatographic fractions and the SPPs (P1–P4) exhibited inhibitory potential against porcine pancreatic alpha-amylase in vitro. Compounds P1 and P2 with IC(50) values 10.01 and 12.10 µM, respectively, showed greater inhibitory potential than the reference acarbose (IC(50) = 13.47 µM). Molecular docking analysis suggests that the SPPs had a strong binding affinity to porcine pancreatic alpha-amylase (PPA), human pancreatic alpha-amylase (HPA), and human salivary alpha-amylase (HSA), interacting with the key active site residues through an array of hydrophobic interactions and hydrogen bonds. The strong interactions of the SPPs with Glu233 and Asp300 residues may disrupt their roles in the acid-base catalytic mechanism and proper orientation of the polymeric substrates, respectively. The interactions with human pancreatic amylase were maintained in a dynamic environment as indicated by the root mean square deviation, radius of gyration, surface accessible surface area, and number of hydrogen bonds computed from the trajectories obtained from a 100-ns molecular dynamics simulation. Key loop regions of HPA that contribute to substrate binding exhibited flexibility and interaction potential toward the compounds as indicated by the root mean square fluctuation. Furthermore, P1 significantly reduced blood glucose levels and area under the curve in albino rats which were orally challenged with starch. Therefore, Gongronema latifolium and its constituent SPPs may be exploited as inhibitors of pancreatic alpha-amylase as an oral policy for impeding postprandial blood glucose rise. Frontiers Media S.A. 2022-08-10 /pmc/articles/PMC9399641/ /pubmed/36032689 http://dx.doi.org/10.3389/fmolb.2022.866719 Text en Copyright © 2022 Ogunyemi, Gyebi, Saheed, Paul, Nwaneri-Chidozie, Olorundare, Adebayo, Koketsu, Aljarba, Alkahtani, Batiha and Olaiya. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Biosciences Ogunyemi, Oludare M. Gyebi, Gideon A. Saheed, Afolabi Paul, Jesse Nwaneri-Chidozie, Victoria Olorundare, Olufunke Adebayo, Joseph Koketsu, Mamoru Aljarba, Nada Alkahtani, Saad Batiha, Gaber El-Saber Olaiya, Charles O. Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth |
title | Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth |
title_full | Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth |
title_fullStr | Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth |
title_full_unstemmed | Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth |
title_short | Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth |
title_sort | inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from gongronema latifolium benth |
topic | Molecular Biosciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399641/ https://www.ncbi.nlm.nih.gov/pubmed/36032689 http://dx.doi.org/10.3389/fmolb.2022.866719 |
work_keys_str_mv | AT ogunyemioludarem inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth AT gyebigideona inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth AT saheedafolabi inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth AT pauljesse inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth AT nwanerichidozievictoria inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth AT olorundareolufunke inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth AT adebayojoseph inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth AT koketsumamoru inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth AT aljarbanada inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth AT alkahtanisaad inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth AT batihagaberelsaber inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth AT olaiyacharleso inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth |